In endometrial cancer (EC), protein arginine methyltransferase 3 (PRMT3)-mediated METTL14 promotes ferroptosis sensitivity by reducing the expression and stability of glutathione peroxidase 4 (GPX4). Here, GPX4 is linked to endometrial cancer.